4-17486449-T-C

Position:

• chr4-17486449-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_000320.3(QDPR):​c.*682A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.651 in 151,892 control chromosomes in the GnomAD database, including 32,510 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.65 (32475 hom., cov: 32)
  • Exomes 𝑓: 0.50 (35 hom.)
• Consequence: QDPR NM_000320.3 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -1.54

Genes affected

QDPR (HGNC:9752): (quinoid dihydropteridine reductase) This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-1.0).
• BP6: Variant 4-17486449-T-C is Benign according to our data. Variant chr4-17486449-T-C is described in ClinVar as [Benign]. Clinvar id is 348138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
QDPR	NM_000320.3	c.*682A>G		3_prime_UTR_variant	7/7	ENST00000281243.10
QDPR	NM_001306140.2	c.*682A>G		3_prime_UTR_variant	6/6
QDPR	NR_156494.2	n.1344A>G		non_coding_transcript_exon_variant	6/6

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
QDPR	ENST00000281243.10	c.*682A>G		3_prime_UTR_variant	7/7	1	NM_000320.3	P1
QDPR	ENST00000513615.5	c.*119+730A>G		intron_variant		2
QDPR	ENST00000706645.1	n.2464A>G		non_coding_transcript_exon_variant	6/6
QDPR	ENST00000507439.5	c.*849A>G		3_prime_UTR_variant, NMD_transcript_variant	6/6	2

Frequencies

GnomAD3 genomes AF: 0.651 AC: 98643 AN: 151564 Hom.: 32448 Cov.: 32

Gnomad AFR AF: 0.565

Gnomad AMI AF: 0.660

Gnomad AMR AF: 0.602

Gnomad ASJ AF: 0.560

Gnomad EAS AF: 0.764

Gnomad SAS AF: 0.682

Gnomad FIN AF: 0.793

Gnomad MID AF: 0.708

Gnomad NFE AF: 0.685

Gnomad OTH AF: 0.648

GnomAD4 exome AF: 0.505 AC: 107 AN: 212 Hom.: 35 Cov.: 0 AF XY: 0.533 AC XY: 65 AN XY: 122

Gnomad4 AMR exome AF: 0.300

Gnomad4 SAS exome AF: 0.500

Gnomad4 FIN exome AF: 1.00

Gnomad4 NFE exome AF: 0.542

Gnomad4 OTH exome AF: 0.333

GnomAD4 genome AF: 0.651 AC: 98716 AN: 151680 Hom.: 32475 Cov.: 32 AF XY: 0.659 AC XY: 48812 AN XY: 74112

Gnomad4 AFR AF: 0.566

Gnomad4 AMR AF: 0.601

Gnomad4 ASJ AF: 0.560

Gnomad4 EAS AF: 0.764

Gnomad4 SAS AF: 0.682

Gnomad4 FIN AF: 0.793

Gnomad4 NFE AF: 0.685

Gnomad4 OTH AF: 0.648

Alfa AF: 0.665 Hom.: 32296

Bravo AF: 0.629

Asia WGS AF: 0.709 AC: 2467 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Dihydropteridine reductase deficiency Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jan 13, 2018

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

-

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-1.0
CADD	Benign	1.7
DANN	Benign	0.47

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs699459; hg19: chr4-17488072;